Roivant Sciences Gets SPAC Deal: What To Expect From This BioPharma, Health Technology CompanyBenzinga • 05/03/21
Montes Archimedes Acquisition (MAAC) Taking Roivant Sciences Public In $7.3 Billion DealPulse2 • 05/03/21
Roivant Sciences and Montes Archimedes Acquisition Corp. (MAAC) to Combine and Create Publicly Traded Leader in Biopharma and Health TechnologyPRNewsWire • 05/03/21